5h ago
Canada’s clean power shortage could put $220 billion in investment at risk, boosting Capital Power’s dividend case
A shortage of clean electricity in Canada could put up to $220 billion in potential capital investment at risk, as demand from mines, factories and data centres rises. Against that backdrop, Capital Power reported second-quarter adjusted funds from operations of $328 million and raised its quarterly dividend by 2%, extending its streak of annual increases to 13 years. The company has also secured Meta as a long-term customer, underscoring the value of contracted clean and dispatchable power when supply is tight.
5h ago
6h ago
Nvidia plans AI server price increases of more than 15% ahead of Aug. 26 earnings
Nvidia plans to raise prices by more than 15% on several AI servers to offset higher costs for components such as memory. The company reported $81.6 billion in revenue last quarter, up 85% year over year, including $75.2 billion from its Data Center business, which rose 92%. Non-GAAP gross margin was 75%, and Nvidia guided fiscal second-quarter revenue to roughly $91 billion while maintaining a 75% non-GAAP gross margin.
6h ago
6h ago
Applied Materials Shares Slide More Than 34% From 52-Week High as Investors Take Profits
Applied Materials has fallen more than 34% from its 52-week high, even as the company posted record Q3 revenue of $9.1 billion, up 25% year over year. Adjusted EPS rose 41% to $3.50, while adjusted gross margin increased to 50.4% and adjusted operating margin reached a record 34%. The pullback comes as AI infrastructure investment continues to support demand for semiconductor equipment. After the sharp decline, the stock’s risk-reward profile appears more attractive.
6h ago
6h ago
Eli Lilly completes $US7.8 billion Centessa deal, drawing attention to orexin drugs for narcolepsy
Eli Lilly has completed a $US7.8 billion acquisition of Centessa, which is developing experimental therapies for rare sleep disorders. The deal has drawn market attention and is seen by some as expanding the imagination around potential “human-enhancement” uses for orexin-targeting medicines. Lilly is the world’s most valuable pharmaceutical company with a $US1.1 trillion market capitalisation, buoyed by the rise of GLP1 weight-loss drugs.
6h ago
6h ago
Archer Aviation teams up with AEG to build L.A. Live vertiport ahead of the 2028 Los Angeles Olympics
Archer Aviation has partnered with AEG to develop a vertiport at L.A. Live in downtown Los Angeles as it works to build an urban air-taxi network ahead of the 2028 Olympic and Paralympic Games. The site is intended to help position the company for elevated transportation demand during the Games. The planned development is part of Archer’s broader effort to put key infrastructure in place before the event.
6h ago
6h ago
Arabica and Robusta Coffee Futures Jump More Than 5% as Brazil Supply Concerns Build
December-delivery arabica coffee futures rose 5.89%, while September-delivery robusta futures gained 5.34%. Rainfall in Brazil’s key producing state of Minas Gerais has recently been just 11% of the historical average, raising drought concerns for supply. By mid-August, Brazil’s coffee harvest was 90% complete, behind 97% a year earlier and the five-year average of 94%. Arabica harvesting lagged further at 86%, compared with 95% last year.
6h ago